Medindia

X

New Artificial Pancreas System to be Tested in Two Clinical Trials

by Vishnuprasad on  January 6, 2016 at 6:09 PM Research News   - G J E 4
Scientists at the University of Virginia School of Medicine have developed a device that can automatically monitor and regulate blood-sugar levels in individuals with type 1 diabetes. The device will undergo final testing in early 2016.
New Artificial Pancreas System to be Tested in Two Clinical Trials
New Artificial Pancreas System to be Tested in Two Clinical Trials
Advertisement

According to scientists, promising results from these clinical trials could lead the U.S. Food and Drug Administration and other international regulatory groups to approve the device for use by people with type 1 diabetes.

‘A new artificial pancreas system can help automatically monitor and regulate blood-sugar levels in individuals with type 1 diabetes.’
Advertisement
The trials will be carried out at nine locations in the U.S. and Europe. The trials will receive around $12.6 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

The first study will test technology developed at UVA by a expert team led by Boris Kovatchev, PhD, director of the UVA Center for Diabetes Technology.

The second trial will also analyze a new control algorithm developed by the team of Dr. Francis Doyle III at the Harvard John A. Paulson School of Engineering and Applied Sciences to examine whether it further improves control of sugar levels.

"To be ultimately successful as an optimal treatment for diabetes, the artificial pancreas needs to prove its safety and efficacy in long-term pivotal trials in the patient's natural environment," Kovatchev said. "Our foremost goal is to establish a new diabetes treatment paradigm: the artificial pancreas is not a single-function device; it is an adaptable, wearable network surrounding the patient in a digital treatment ecosystem."



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All